Back to User profile » Dr Michael Camilleri
Papers published by Dr Michael Camilleri:
Pharmacotherapy for Obesity: Recent Updates
Fredrick TW, Camilleri M, Acosta A
Clinical Pharmacology: Advances and Applications 2025, 17:305-327
Published Date: 19 September 2025
Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 Studies
Camilleri M, Hale M, Morlion B, Tack J, Webster L, Wild J
Journal of Pain Research 2021, 14:2179-2189
Published Date: 16 July 2021
Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals
Webster LR, Camilleri M, Finn A
Substance Abuse and Rehabilitation 2016, 7:81-86
Published Date: 14 June 2016
The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects
Sathananthan M, Ikramuddin S, Swain JM, Shah M, Piccinini F, Dalla Man C, Cobelli C, Rizza RA, Camilleri M, Vella A
Diabetes, Metabolic Syndrome and Obesity 2014, 7:305-312
Published Date: 11 July 2014
Role of prucalopride, a serotonin (5-HT4) receptor agonist, for the treatment of chronic constipation
Banny S Wong, Noriaki Manabe, Michael Camilleri
Clinical and Experimental Gastroenterology 2010, 3:49-56
Published Date: 24 May 2010